{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:22:59Z","timestamp":1790688179656,"version":"4.1.0"},"reference-count":41,"publisher":"American Diabetes Association","issue":"9","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:p>Mechanisms by which autosomal recessive mutations in Lmna cause familial partial lipodystrophy type 2 (FPLD2) are poorly understood. To investigate the function of lamin A\/C in adipose tissue, we created mice with an adipocyte-specific loss of Lmna (LmnaADKO). Although LmnaADKO mice develop and maintain adipose tissues in early postnatal life, they show a striking and progressive loss of white and brown adipose tissues as they approach sexual maturity. LmnaADKO mice exhibit surprisingly mild metabolic dysfunction on a chow diet, but on a high-fat diet they share many characteristics of FPLD2 including hyperglycemia, hepatic steatosis, hyperinsulinemia, and almost undetectable circulating adiponectin and leptin. Whereas LmnaADKO mice have reduced regulated and constitutive bone marrow adipose tissue with a concomitant increase in cortical bone, FPLD2 patients have reduced bone mass and bone mineral density compared with controls. In cell culture models of Lmna deficiency, mesenchymal precursors undergo adipogenesis without impairment, whereas fully differentiated adipocytes have increased lipolytic responses to adrenergic stimuli. LmnaADKO mice faithfully reproduce many characteristics of FPLD2 and thus provide a unique animal model to investigate mechanisms underlying Lmna-dependent loss of adipose tissues.<\/jats:p>","DOI":"10.2337\/db20-1001","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T16:05:14Z","timestamp":1622822714000},"page":"1970-1984","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":25,"title":["Adipocyte-Specific Deletion of Lamin A\/C Largely Models Human Familial Partial Lipodystrophy Type 2"],"prefix":"10.2337","volume":"70","clinical-trial-number":[{"clinical-trial-number":"nct03087253","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Callie A.S.","family":"Corsa","sequence":"first","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn M.","family":"Walsh","sequence":"additional","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devika P.","family":"Bagchi","sequence":"additional","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Foss Freitas","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziru","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Hardij","sequence":"additional","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Granger","sequence":"additional","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Schill","sequence":"additional","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth T.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"Maung","sequence":"additional","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth D.","family":"Azaria","sequence":"additional","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"Rothberg","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif A.","family":"Oral","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6907-7960","authenticated-orcid":false,"given":"Ormond A.","family":"MacDougald","sequence":"additional","affiliation":[{"name":"Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI"},{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"key":"2022031309281603600_B1","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1194\/jlr.M800491-JLR200","article-title":"The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation","volume":"50","author":"Wojtanik","year":"2009","journal-title":"J Lipid Res"},{"key":"2022031309281603600_B2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/hmg\/ddi480","article-title":"Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy","volume":"15","author":"Boguslavsky","year":"2006","journal-title":"Hum Mol Genet"},{"key":"2022031309281603600_B3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1083\/jcb.147.5.913","article-title":"Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy","volume":"147","author":"Sullivan","year":"1999","journal-title":"J Cell Biol"},{"key":"2022031309281603600_B4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4161\/nucl.2.3.15731","article-title":"Post-natal myogenic and adipogenic developmental: defects and metabolic impairment upon loss of A-type lamins","volume":"2","author":"Kubben","year":"2011","journal-title":"Nucleus"},{"key":"2022031309281603600_B5","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/hmg\/ddt509","article-title":"Deregulation of Fragile X-related protein 1 by the lipodystrophic lamin A p.R482W mutation elicits a myogenic gene expression program in preadipocytes","volume":"23","author":"Oldenburg","year":"2014","journal-title":"Hum Mol Genet"},{"key":"2022031309281603600_B6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11892-018-1099-9","article-title":"Phenotypic and genetic characteristics of lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities","volume":"18","author":"Akinci","year":"2018","journal-title":"Curr Diab Rep"},{"key":"2022031309281603600_B7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ecl.2016.06.012","article-title":"Lipodystrophy syndromes","volume":"45","author":"Hussain","year":"2016","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2022031309281603600_B8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbalip.2008.12.014","article-title":"Lipodystrophies: disorders of adipose tissue biology","volume":"1791","author":"Garg","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"2022031309281603600_B9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/19491034.2018.1454167","article-title":"Lipodystrophic laminopathies: diagnostic clues","volume":"9","author":"Guill\u00edn-Amarelle","year":"2018","journal-title":"Nucleus"},{"key":"2022031309281603600_B10","first-page":"33","article-title":"Familial lipoatrophic diabetes with dominant transmission. A new syndrome","volume":"43","author":"Dunnigan","year":"1974","journal-title":"Q J Med"},{"key":"2022031309281603600_B11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","article-title":"Nuclear lamin A\/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy","volume":"9","author":"Cao","year":"2000","journal-title":"Hum Mol Genet"},{"key":"2022031309281603600_B12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy","volume":"24","author":"Shackleton","year":"2000","journal-title":"Nat Genet"},{"key":"2022031309281603600_B13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ng0398-292","article-title":"Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22","volume":"18","author":"Peters","year":"1998","journal-title":"Nat Genet"},{"key":"2022031309281603600_B14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1365-2265.2011.04208.x","article-title":"Histological and molecular features of lipomatous and nonlipomatous adipose tissue in familial partial lipodystrophy caused by LMNA mutations","volume":"76","author":"Ara\u00fajo-Vilar","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2022031309281603600_B15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/cen.13984","article-title":"Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2","volume":"91","author":"Resende","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2022031309281603600_B16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.diabet.2018.09.006","article-title":"Cardiometabolic assessment of lamin A\/C gene mutation carriers: a phenotype-genotype correlation","volume":"45","author":"Kwapich","year":"2019","journal-title":"Diabetes Metab"},{"key":"2022031309281603600_B17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbrc.2017.11.008","article-title":"FPLD2 LMNA mutation R482W dysregulates iPSC-derived adipocyte function and lipid metabolism","volume":"495","author":"Friesen","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"2022031309281603600_B18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.diff.2014.12.002","article-title":"Tissue specific loss of A-type lamins in the gastrointestinal epithelium can enhance polyp size","volume":"89","author":"Wang","year":"2015","journal-title":"Differentiation"},{"key":"2022031309281603600_B19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cmet.2011.02.005","article-title":"Transcriptional control of adipose lipid handling by IRF4","volume":"13","author":"Eguchi","year":"2011","journal-title":"Cell Metab"},{"issue":"2","key":"2022031309281603600_B20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/oby.23049","article-title":"The metabolic equivalent BMI in patients with familial partial lipodystrophy (FPLD) compared with those with severe obesity","volume":"29","author":"Koo","year":"2021","journal-title":"Obesity"},{"key":"2022031309281603600_B21","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1096\/fj.04-3204fje","article-title":"Mesenchymal stem cells from the outer ear: a novel adult stem cell model system for the study of adipogenesis","volume":"19","author":"Rim","year":"2005","journal-title":"FASEB J"},{"key":"2022031309281603600_B22","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1172\/JCI63604","article-title":"Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition","volume":"122","author":"Mori","year":"2012","journal-title":"J Clin Invest"},{"key":"2022031309281603600_B23","doi-asserted-by":"crossref","first-page":"16348","DOI":"10.1074\/jbc.M100128200","article-title":"p300 coactivates the adipogenic transcription factor CCAAT\/enhancer-binding protein alpha","volume":"276","author":"Erickson","year":"2001","journal-title":"J Biol Chem"},{"key":"2022031309281603600_B24","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1172\/JCI126173","article-title":"G-CSF partially mediates effects of sleeve gastrectomy on the bone marrow niche","volume":"129","author":"Li","year":"2019","journal-title":"J Clin Invest"},{"key":"2022031309281603600_B25","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1038\/ncomms8808","article-title":"Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues","volume":"6","author":"Scheller","year":"2015","journal-title":"Nat Commun"},{"key":"2022031309281603600_B26","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1006\/bbrc.2002.6466","article-title":"Characterization of adiposity and metabolism in Lmna-deficient mice","volume":"291","author":"Cutler","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"2022031309281603600_B27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molmet.2018.05.006","article-title":"Surplus fat rapidly increases fat oxidation and insulin resistance in lipodystrophic mice","volume":"13","author":"Girousse","year":"2018","journal-title":"Mol Metab"},{"key":"2022031309281603600_B28","doi-asserted-by":"crossref","first-page":"101221","DOI":"10.1016\/j.molmet.2021.101221","article-title":"Ube2i deletion in adipocytes causes lipoatrophy in mice","volume":"48","author":"Cox","year":"2021","journal-title":"Mol Metab"},{"key":"2022031309281603600_B29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.metabol.2019.03.003","article-title":"Systemic PPAR\u03b3 deletion in mice provokes lipoatrophy, organomegaly, severe type 2 diabetes and metabolic inflexibility","volume":"95","author":"Gilardi","year":"2019","journal-title":"Metabolism"},{"key":"2022031309281603600_B30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cmet.2009.01.002","article-title":"Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy","volume":"9","author":"Cort\u00e9s","year":"2009","journal-title":"Cell Metab"},{"key":"2022031309281603600_B31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/nyas.12327","article-title":"What\u2019s the matter with MAT? Marrow adipose tissue, metabolism, and skeletal health","volume":"1311","author":"Scheller","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"2022031309281603600_B32","first-page":"170","article-title":"Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety)","volume":"84","author":"Garg","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031309281603600_B33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/joim.12718","article-title":"Clinical implications of bone marrow adiposity","volume":"283","author":"Veldhuis-Vlug","year":"2018","journal-title":"J Intern Med"},{"key":"2022031309281603600_B34","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1101\/gad.12.20.3168","article-title":"Life without white fat: a transgenic mouse","volume":"12","author":"Moitra","year":"1998","journal-title":"Genes Dev"},{"key":"2022031309281603600_B35","doi-asserted-by":"crossref","first-page":"18656","DOI":"10.1073\/pnas.1314863110","article-title":"Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPAR\u03b3","volume":"110","author":"Wang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022031309281603600_B36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","article-title":"Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy","volume":"401","author":"Shimomura","year":"1999","journal-title":"Nature"},{"key":"2022031309281603600_B37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm1262","article-title":"Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy","volume":"11","author":"Pajvani","year":"2005","journal-title":"Nat Med"},{"key":"2022031309281603600_B38","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cmet.2016.12.008","article-title":"Adipocyte dynamics and reversible metabolic syndrome in mice with an inducible adipocyte-specific deletion of the insulin receptor","volume":"25","author":"Sakaguchi","year":"2017","journal-title":"Cell Metab"},{"key":"2022031309281603600_B39","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.2337\/diabetes.53.suppl_3.S215","article-title":"The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes","volume":"53","author":"Winzell","year":"2004","journal-title":"Diabetes"},{"key":"2022031309281603600_B40","first-page":"3431","article-title":"Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy","volume":"85","author":"Hegele","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031309281603600_B41","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1083\/jcb.201707090","article-title":"Lipodystrophic laminopathy: lamin A mutation relaxes chromatin architecture to impair adipogenesis","volume":"216","author":"Elzeneini","year":"2017","journal-title":"J Cell Biol"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/70\/9\/1970\/627962\/db201001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/70\/9\/1970\/627962\/db201001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T14:35:49Z","timestamp":1699108549000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/70\/9\/1970\/137806\/Adipocyte-Specific-Deletion-of-Lamin-A-C-Largely"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,6,4]]},"published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db20-1001","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,4]]}}}